Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biopharma Buys 'Insurance Policy Ahead of First Commercial Launch'

The terms of the financial transaction and the potential reasons for it are discussed in a BTIG report. In a June 26 research note, BTIG analyst Thomas Shrader reported that Esperion Therapeutics Inc. (ESPR:NASDAQ) agreed to an "up to $200 capped, tier...
Streetwise Reports | July 3, 2019 |

Cypress: 5 first steps to a lithium mine

Building a mine is a succession of confidence-building steps. In the initial phases of exploration, when land is staked, samples are taken (channel, rock, chip) and surveys (geochemical and geophysical) are conducted, junior resource investors have a low level of confidence ...
Richard (Rick) Mills | May 2, 2019 |

Kardashian-Style News Bomb: Already Big Ashram Gets Bigger And Bigger

Bigger is Better (at least in this respect) What a pleasant surprise! The Ashram Rare Earth and Fluorspar Deposit continues to grow. As announced today by Commerce Resources Corp. , recent core assays for vertical drilling at Ashram has disc...
Stephan Bogner | November 28, 2019 |

Exicure's Collaboration with Allergan on Treating Hair Loss Disorders Sends Shares Higher

Shares of Exicure Inc. opened 30% higher today after the firm reported that it entered into a collaboration agreement with Allergan to discover and develop SNA-based treatments for hair loss disorders. The terms of the deal provide for a $25 million upfront payment to Exicure ...
Streetwise Reports | November 15, 2019 |

What Is Vanadium and Why Should I Care?

Summary Vanadium is the 20th most abundant element in the earth’s crust and the 13th most available metal, but it is a challenge to recover. Heap leaching is a method that has taken low grade deposits (gold, copper, nickel and cobalt) and recovers sufficient ...
Michael Drozd | March 29, 2019 |

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'

The study data and their implications are provided in a BTIG report. In an Aug. 29 research note, BTIG analyst Thomas Shrader reported that just released topline data are "as hoped" from Esperion Therapeutics Inc.'s (ESPR:NASDAQ) Phase 2 trial of bempedoic acid-ezet...
Streetwise Reports | September 5, 2019 |

Cypress Development Delivers Strong PFS on Clayton Valley Lithium Project

Cypress Development Corp. (CYP:TSX.V; CYDVF:OTCQB; C1Z1:FSE) owns 100% of a giant, leachable, lithium-bearing claystone-hosted resource, the Clayton Valley Lithium Project (CVLP), adjacent to Albemarle Corp.'s Silver Peak brine operations in Nevada. The company has an En...
Streetwise Reports | June 9, 2020 |

EyeGate Pharma Shares Looking Up on Pivotal PRK Ocular Bandage Gel Study Data

EyeGate Pharmaceuticals shares opened nearly 85% higher today after the company reported select topline data demonstrating that it met its primary endpoint in its cornea wound repairs pivotal photorefractive keratectomy study using the firm's Ocular Bandage Gel eye drop. ...
Streetwise Reports | November 25, 2019 |

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment

Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. This morning biopharmac...
Streetwise Reports | November 27, 2019 |

America’s critical metals mine

The United States is dependent on South Africa, the politically unstable Democratic Republic of Congo (DRC), and an increasingly aggressive China for over half of its supply of critical minerals - defined as minerals that are essential to a country’s econom...
Richard (Rick) Mills | June 20, 2019 |
1 2 3 4 5 6 7